NCT02905695

Post-partum Perineal Pain - Chirocaine®

Contribution of the Local Infiltration of Chirocaine® in the Management of the Post-partum Perineal Pain After Episiotomy or First-degree Tear

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 110 (actual)
• Sponsor: Hopital Foch · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The aim of this placebo-controlled clinical trial is to assess the effectiveness of the local infiltration of the analgesic Chirocaïne® on perineal pain after episiotomy or first-degree tear. The pain intensity is measured in immediate postpartum period by using a numerical rating scale (NRS) at the following times: H2, H4, H8, H12, H24, H36, H48 during rest, defecation and during activities. The safety of Chirocaïne® and the patient satisfaction are also evaluated at each time.

Conditions

• Post-partum Perineal Pain
• Episiotomy
• Vaginal Tear

Interventions

Type	Name	Description
DRUG	Chirocaine
OTHER	Placebo

Timeline

• Start date: 2011-01-01
• Primary completion: 2015-01-01
• Completion: 2016-07-01
• First posted: 2016-09-19
• Last updated: 2016-09-19

Locations

1 site across 1 country: France